News
Cohance Lifesciences consolidated net profit declines 83.77% in the March 2026 quarter
13-May-2026 | 07:26
Sales decline 26.33% to Rs 619.12 crore
Net profit of Cohance Lifesciences declined 83.77% to Rs 19.55 crore in the quarter ended March 2026 as against Rs 120.43 crore during the previous quarter ended March 2025. Sales declined 26.33% to Rs 619.12 crore in the quarter ended March 2026 as against Rs 840.42 crore during the previous quarter ended March 2025.
For the full year,net profit declined 63.22% to Rs 179.23 crore in the year ended March 2026 as against Rs 487.34 crore during the previous year ended March 2025. Sales declined 13.03% to Rs 2268.55 crore in the year ended March 2026 as against Rs 2608.50 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 619.12 | 840.42 | -26 | 2268.55 | 2608.50 | -13 |
| OPM % | 15.94 | 27.27 | - | 18.82 | 30.56 | - |
| PBDT | 87.65 | 230.82 | -62 | 423.84 | 825.21 | -49 |
| PBT | 36.42 | 176.65 | -79 | 236.51 | 658.41 | -64 |
| NP | 19.55 | 120.43 | -84 | 179.23 | 487.34 | -63 |
Powered by Capital Market - Live News
